Search clinical trials for: gemtuzumab ozogamicin (GO)
Total 985 results
-
Hoffmann-La RocheRecruitingLocally Advanced or Metastatic Breast CancerFrance, Belgium, United States, Korea, Republic of, Taiwan, Brazil, China, Italy, Argentina, Jordan, Mexico, Germany, Portugal, Spain, Thailand, Turkey, United Kingdom, Kenya, Hungary, Poland, Colombia, India, Oman, Uganda, United Arab... and more
-
Cellectis S.A.RecruitingB-cell Acute Lymphoblastic LeukemiaUnited States, France
-
Mabscale, LLCActive, not recruitingHealthy MenRussian Federation
-
Hoffmann-La RocheCompletedBreast CancerKorea, Republic of
-
Hoffmann-La RocheCompletedBreast CancerAustralia, Spain, United Kingdom, Germany, Belgium, Italy, Finland, Netherlands
-
Institut Català d'OncologiaFundación Sociedad Española de Oncologia Médica; Instituto de Salud Carlos III and other collaboratorsRecruitingNeoplasms | Breast Cancer | HER2-positive Breast CancerSpain
-
Hoffmann-La RocheActive, not recruitingInflammatory Breast Cancer | Early Breast Cancer | Locally Advanced Breast CancerCanada, Croatia, Spain, Argentina, Mexico, Korea, Republic of, Bosnia and Herzegovina, Brazil, Costa Rica, Turkey, Singapore, Bulgaria, South Africa, India, Peru, Kenya, Chile
-
PfizerUCB PharmaCompletedLymphoma, B-CellKorea, Republic of, Canada, Belgium, Singapore, United States, Hong Kong, Japan, United Kingdom, France
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedDepression | Leukemia | Fatigue | Psychosocial Effects of Cancer and Its Treatment | Musculoskeletal ComplicationsUnited States
-
Institut fuer FrauengesundheitSamsung Bioepis Co., Ltd.RecruitingBreast Cancer | Breast Neoplasms | HER2-positive Breast Cancer | Breast Cancer FemaleGermany
-
University of Michigan Rogel Cancer CenterCompleted
-
Hospital Universitario Dr. Jose E. GonzalezWithdrawn
-
Muğla Sıtkı Koçman UniversityCompletedMultiple Sclerosis | Telerehabilitation | Autoimmune Disorder | Exercise ProgramTurkey
-
Institute of Hematology & Blood Diseases Hospital...Not yet recruiting
-
Bolt Biotherapeutics, Inc.Hoffmann-La RocheRecruitingMetastatic Breast Cancer | HER2-positive Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterUniversity of Pennsylvania; Genentech, Inc.CompletedBreast CancerUnited States
-
Children's Hospital Los AngelesWithdrawn
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Bayer; University of California, Los Angeles; Northwestern... and other collaboratorsCompletedLymphoplasmacytic Lymphoma | Waldenstrom's MacroglobulinemiaUnited States
-
Istanbul University - Cerrahpasa (IUC)CompletedMultiple Sclerosis | Gait Disorders, Neurologic | Upper Extremity ProblemTurkey
-
Gilead SciencesWithdrawnDiffuse Large B-cell Lymphoma | NHL | Non Hodgkin's Lymphoma | Aggressive NHLUnited States
-
University of California, San FranciscoTerminatedSevere Combined ImmunodeficiencyUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteGenentech, Inc.RecruitingHER2-positive Breast Cancer | Leptomeningeal Disease | Leptomeningeal MetastasisUnited States
-
Helsinki University Central HospitalActive, not recruiting
-
University of British ColumbiaGenzyme, a Sanofi CompanyCompletedRelapsing Remitting Multiple SclerosisCanada
-
M.D. Anderson Cancer CenterTerminated
-
M.D. Anderson Cancer CenterBerlex Laboratories, Inc.CompletedChronic Lymphocytic LeukemiaUnited States
-
EirGenix, Inc.Sacura GmbHCompleted
-
M.D. Anderson Cancer CenterNot yet recruitingB-cell Acute Lymphocytic Leukemia | Relapsed/RefractoryUnited States
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingHER2-positive Breast CancerChina
-
Eli Lilly and CompanyCoLucid PharmaceuticalsCompleted
-
Shanghai Zhangjiang Biotechnology Limited CompanySuspendedB-cell Chronic Lymphocytic LeukemiaChina
-
Kimberly BlackwellTerminatedHER2 Positive Untreated Metastatic Breast Cancer | Asymptomatic or Low Symptomatic Brain Metastasis in Breast CancerUnited States
-
Weill Medical College of Cornell UniversityGilead SciencesTerminatedFollicular LymphomaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLeukemiaUnited States
-
Cancer Research UKRoyal Marsden NHS Foundation Trust; Hoffmann-La Roche; University of Manchester; University of BirminghamRecruitingColorectal Neoplasms | Ovarian Neoplasms | Solid Tumor | Gallbladder Neoplasms | Prostatic Neoplasm | Pancreatic Neoplasm | Lung Neoplasm | Haematological Malignancy | Urinary Bladder Neoplasm | Skin Neoplasm | Salivary Gland NeoplasmUnited Kingdom
-
University of ChicagoGenzyme, a Sanofi CompanyCompleted
-
M.D. Anderson Cancer CenterLeudositeTerminatedLymphoma, B-Cell | Lymphoma, T-Cell | Lymphoma, Low-Grade | Leukemia, Lymphocytic, Acute | Leukemia, Lymphocytic, ChronicUnited States
-
Hoffmann-La RocheCompletedBreast CancerCanada, Spain, France, United Kingdom, Italy
-
Genzyme, a Sanofi CompanyBayer Healthcare Pharmaceuticals, Inc./Bayer Schering PharmaCompletedB-Cell Chronic Lymphocytic Leukemia (B-CLL)United Kingdom, Belgium, France, United States, Czech Republic, Serbia
-
Hadassah Medical OrganizationBayerWithdrawnAcute Myeloid Leukemia | Myelodysplastic SyndromeIsrael
-
Charite University, Berlin, GermanyDeutsche Klinik fuer Diagnostik; University Hospital Carl Gustav CarusUnknownChronic Lymphocytic LeukemiaGermany
-
PfizerUCB PharmaCompletedAcute Lymphoblastic LeukemiaUnited States, Canada, France, Spain, China, United Kingdom, Australia, Taiwan, Singapore, Korea, Republic of, Japan, Germany, Czechia, Poland, Italy, Netherlands, Argentina, Finland, Hungary, Sweden
-
TakedaTerminatedRheumatoid ArthritisUnited States, Argentina, Canada, Czech Republic, Germany, Hungary, Italy, Mexico, Poland, Spain, United Kingdom
-
Mario Negri Institute for Pharmacological ResearchCompleted
-
Seagen Inc.Merck Sharp & Dohme LLCRecruitingHER2 Positive Breast CancerUnited States, Taiwan, Canada, Korea, Republic of, Austria, China, Spain, Japan, France, Italy, Switzerland, Australia, Belgium, Brazil, Germany, Portugal, United Kingdom, Netherlands, Czechia, Greece, Chile, Finland, Poland
-
David Garcia CincaFundacion Clinic per a la Recerca BiomédicaNot yet recruiting
-
Qamar KhanRecruitingHER2-positive Breast CancerUnited States
-
Gilead SciencesCompletedPancreatic CancerUnited States, Russian Federation
-
BayerCompleted